Skip to main content

Peer Review reports

From: Treatment of a mouse model of ankylosing spondylitis with exogenous sclerostin has no effect on disease progression

Original Submission
24 Jul 2015 Submitted Original manuscript
22 Sep 2015 Reviewed Reviewer Report - Denis Poddubnyy
24 Sep 2015 Reviewed Reviewer Report - Ruben Burgos-Vargas
31 Oct 2015 Author responded Author comments - Katelin Haynes
Resubmission - Version 2
31 Oct 2015 Submitted Manuscript version 2
Publishing
20 Nov 2015 Editorially accepted
26 Nov 2015 Article published 10.1186/s12891-015-0823-8

You can find further information about peer review here.

Back to article page